JENNIFER WARD: Open Payments
NPI 1356613004 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,945 in 99 payments from 26 companies in 2025. Trend: 2023 $1,232 · 2024 $1,525 · 2025 $1,945
Food & beverage: $1,945
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $296 |
| AstraZeneca Pharmaceuticals LP | 7 | $257 |
| Lilly USA, LLC | 11 | $216 |
| ABBVIE INC. | 11 | $204 |
| GlaxoSmithKline, LLC. | 15 | $185 |
| SHIELD THERAPEUTICS INC | 3 | $94 |
| Novo Nordisk Inc | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Organon LLC | 3 | $52 |
Products named: FARXIGA, PREVNAR 20, TRELEGY ELLIPTA, MOUNJARO, NURTEC ODT, VRAYLAR, ACCRUFER, Ozempic.
Industry payments across OK — which companies pay providers there.
